Subscribe

Editorial

DOI: 10.4244/EIJ-E-26-00001

Privileged witnesses: how interventional cardiologists can validate experimental evidence in practice

Javier Escaned1, MD, PhD; Guus de Waard2, MD, PhD

Immersed in our everyday activities and busy work schedules, we run the risk of failing to appreciate our privileged position as interventional cardiologists to witness and gain insights into many aspects of cardiac physiology. Fortunately, every now and then, we come across fresh observations that support or reinforce a body of knowledge largely obtained in the experimental laboratory. This is indeed the case for the research published on coronary flow regulation in this issue of EuroIntervention by Marin and colleagues1.

To trace the context of this research, we should go back to the French physiologist Claude Bernard, who, in 1865, coined the term “milieu intérieur” and the associated concept of homeostasis to describe the steady internal physical and chemical conditions that are autonomously maintained in living organisms. One specific case of homeostasis is regulating arterial blood supply under shifting conditions. In 1902, Bayliss found that hindlimb arterioles regulate flow through an intrinsic myogenic reflex that reacts to variations of intraluminal pressure, thus keeping flow constant before arterial pressure shifts2, and in 1959, Lassen demonstrated the existence of a cerebral autoregulation curve maintaining stable blood flow across a wide arterial pressure range3. In the coronary circulation, Gould and colleagues demonstrated that, when a coronary stenosis is present, autoregulation causes compensatory microcirculatory dilatation to preserve resting blood supply to the myocardium4. The mechanism proved to be so effective that only when the severity of the stenosis reaches 85% diameter stenosis or more, this autoregulatory reserve became exhausted, and resting flow declined. This finding explains why myocardial ischaemia does not occur in the resting state until the stenosis becomes critical. Effort angina, on the other hand, is explained by the fact that maximal hyperaemic flow decreases gradually as stenosis severity progresses.

In 2015, the European IDEAL collaborative study reproduced the findings of Gould et al for the first time in 301 patients using intracoronary Doppler flow wires5. The study revealed the progressive increase of the transstenotic pressure gradient with increasing stenosis severity and the compensatory reduction of microvascular resistance to maintain a constant resting hyperaemic flow, as Figure 1 shows. Now, Marin et al report the findings of an elegant study in 52 patients based on continuous saline thermodilution measurements, a technique which provides highly accurate measurements of coronary blood flow and microvascular resistance1, confirming that percutaneous coronary intervention (PCI) reduces both resting and hyperaemic epicardial resistance. Under resting conditions, relieving the stenosis means that the microcirculation constricts once again, to avoid unnecessarily oversupplying the myocardium of precious oxygen-rich arterial blood. On the contrary, when microvascular constriction in the smaller coronary arterioles is abolished by high-dose adenosine, microcirculatory resistance remains unchanged after PCI. Because the stenotic epicardial resistor is removed, hyperaemic coronary flow increases after PCI, and the authors find that fractional flow reserve (FFR) predicts this increase in hyperaemic flow. These changes in coronary haemodynamics can also be worked out from Figure 1 as a leftward shift related to decreasing stenosis severity with PCI.

The findings of the authors are of great interest, not only to confirm the experimental observations made previously, but also to address any remaining scientific doubt pertaining to the validity of physiological frameworks of both coronary autoregulation and FFR as the present observations were made (1) within humans, (2) under the most controlled circumstances by measuring within the same patient in the presence of a stenosis (pre-PCI) and without a stenosis (post-PCI), (3) using an advanced method to accurately measure coronary blood flow, and (4) confirming the observations not just in a single patient, but in a sufficiently large cohort. For all this, and for reminding us of the importance of keeping our curiosity alive as clinicians and scientists, the authors deserve heartfelt congratulations.

Figure 1. The relationships between the transstenotic pressure gradient, stenosis severity, microvascular resistance, and coronary flow. The graphs demonstrate these relationships at rest (A) and during hyperaemia (B). PCI: percutaneous coronary intervention

Conflict of interest statement

J. Escaned declares consulting fees and honoraria from Abbott, Boston Scientific, and Philips. G. de Waard has no conflicts of interest to declare.

Volume 22 Number 5
Mar 2, 2026
Volume 22 Number 5
View full issue


Key metrics

Suggested by Cory

EXPERT REVIEW

10.4244/EIJ-D-17-00503 Aug 25, 2017
State of the art: pressure wire and coronary functional assessment
Echavarria-Pinto M et al
free

10.4244/EIJV17I4A47 Jul 20, 2021
Coronary flow capacity: where to next?
Johnson NP and Gould K
free

10.4244/AIJV14I2A19 Jun 20, 2018
Time for caution interpreting coronary physiology in aortic stenosis?
Davies J and Piek J
free

Editorial

10.4244/EIJ-E-24-00022 Jun 3, 2024
Epicardial inflow versus myocardial distribution: average regional transmural coronary flow is not enough
Johnson NP and Gould K
free

10.4244/EIJV13I2A20 Jun 2, 2017
Coronary physiological parameters at a crossroads
Davies J et al
free

State-of-the-Art Review

10.4244/EIJ-D-20-00988 Apr 2, 2021
Optimising physiological endpoints of percutaneous coronary intervention
Al-Lamee R et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
What are the key findings of the study published in EuroIntervention by Marin and colleagues?
What are the advantages of the methods used in this study compared to previous experimental observations?
What are the potential limitations or areas for further research identified in the study?
What are the key factors that the authors highlight as important for clinicians and scientists to maintain their curiosity and make fresh observations?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved